You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Merck
Harvard Business School
Colorcon
Moodys

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Spironolactone - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for spironolactone and what is the scope of patent protection?

Spironolactone is the generic ingredient in three branded drugs marketed by Cmp Dev Llc, Pfizer, Accord Hlthcare, Actavis Elizabeth, Amneal Pharms, Ascot, Aurobindo Pharma Ltd, Chartwell Rx, Ivax Pharms, Jubilant Generics, Lederle, Mutual Pharm, Mylan, Oxford Pharms, Purepac Pharm, Sun Pharm Industries, Superpharm, Upsher Smith, Vangard, Warner Chilcott, Watson Labs, and Zydus Pharms, and is included in twenty-five NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Spironolactone has three patent family members in three countries.

There are sixteen drug master file entries for spironolactone. Thirty-nine suppliers are listed for this compound.

Drug Prices for spironolactone

See drug prices for spironolactone

Drug Sales Revenue Trends for spironolactone

See drug sales revenues for spironolactone

Recent Clinical Trials for spironolactone

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alzheimer's AssociationPhase 4
Emory UniversityPhase 4
Chiang Mai UniversityPhase 3

See all spironolactone clinical trials

Pharmacology for spironolactone
Medical Subject Heading (MeSH) Categories for spironolactone

US Patents and Regulatory Information for spironolactone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cmp Dev Llc CAROSPIR spironolactone SUSPENSION;ORAL 209478-001 Aug 4, 2017 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Oxford Pharms SPIRONOLACTONE spironolactone TABLET;ORAL 040750-002 Aug 29, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Pfizer ALDACTONE spironolactone TABLET;ORAL 012151-010 Dec 30, 1983 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Actavis Elizabeth SPIRONOLACTONE spironolactone TABLET;ORAL 040353-003 Mar 15, 2006 DISCN No No   Start Trial   Start Trial   Start Trial
Actavis Elizabeth SPIRONOLACTONE spironolactone TABLET;ORAL 040353-001 Jul 29, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan SPIRONOLACTONE spironolactone TABLET;ORAL 087086-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan SPIRONOLACTONE spironolactone TABLET;ORAL 040424-002 Aug 20, 2001 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Colorcon
AstraZeneca
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.